CLINICAL ENCOUNTERS
ANKYLOSING SPONDYLITIS
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
Salah
|
|
|
Can be both
|
|
|
Correct
|
|
|
None of the above
|
Detailed explanation-1: -The drugs in this class include Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab).
Detailed explanation-2: -Golimumab injection comes as a solution (liquid) to inject subcutaneously (under the skin) or intravenously (into a vein). When golimumab is given subcutaneously to treat rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis, it is usually given once a month.
Detailed explanation-3: -Infliximab and adalimumab comprise the main part of anti-TNF agents; infliximab was first to be approved for the treatment of UC, followed by adalimumab in several years. Infliximab is administered by intravenous infusion in every 8 weeks after induction, while adalimumab is injected subcutaneously in every 2 weeks.